Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
H. Thajudeen et al. / Tetrahedron Letters 51 (2010) 1303–1305
1305
7. Sinha, S.; Srivastava, R.; De Clercq, E.; Singh, R. K. Nucleosides Nucleotides Nucleic
Acids 2004, 23, 1815.
8. Dinsmore, C. J.; Beshore, D. C. Tetrahedron 2002, 58, 3297.
9. Campo, V. L.; Martins, M. B.; da Silva, C. H. T. P.; Carvalho, I. Tetrahedron 2009,
65, 5343.
10. Zeng, Y.; Li, Q.; Hanzlika, R. P.; Aube, J. Bioorg. Med. Chem. Lett. 2005, 11, 3034.
11. Tullberg, M.; Grøtli, M.; Luthman, K. Tetrahedron 2006, 62, 7484.
12. Fischer, P. M. J. Pept. Sci. 2003, 9, 9.
3.6 mmol) were added to a solution of
L
-proline methyl ester hydrochloride
(0.5 g, 3.0 mmol) in DMF. The reaction mixture was stirred at room
temperature overnight. The DMF was removed in vacuo and the residue was
diluted in EtOAc, washed with NaHCO3, brine, dried over anhydrous Na2SO4,
and filtered. The solvent was evaporated in vacuo. The resulting crude product
was purified by column chromatography using silica gel (ethyl acetate/hexane,
1:1) affording the corresponding linear dipeptide.
27. Representative experimental procedure for cyclization:
13. Martins, M. B.; Carvalho, I. Tetrahedron 2007, 63, 9923.
14. Wang, H.; Ganesan, A. Tetrahedron Lett. 1997, 38, 4327.
15. Wang, H.; Usui, T.; Osada, H.; Ganesan, A. J. Med. Chem. 2000, 43, 1577.
16. Cui, C. B.; Kakeya, H.; Osada, H. Tetrahedron 1996, 52, 12651.
17. Houston, D. R.; Synstad, B.; Eijsink, V. G. H.; Stark, M. J. R.; Eggleston, I. M.; van
Aalten, D. M. F. J. Med. Chem. 2004, 47, 5713.
N-Boc-Tyr-L-proline methyl ester held in a round-bottomed flask was dissolved
in water at a ratio of 20 mL/mmol. The reaction vessel was fixed into a stainless
autoclave with a pressure regulating system. The autoclave was sealed and the
mixture was heated to 130 °C for 4 h. The reaction was then stopped by cooling
and depressurizing the autoclave. Water was evaporated in vacuo, the
remaining residue was purified by column chromatography using silica gel
(MeOH/MC, 0.5:9.5).
18. Watanabe, M.; Sato, T.; Inomata, H.; Smith, R. L., Jr.; Arai, K.; Kruse, A.; Dinjus, E.
Chem. Rev. 2004, 104, 5803.
Cyclo-L-Tyr-L
-Pro: White amorphous solid; Rf 0.16 (MeOH:MC, 0.5:9.5); 1H NMR
19. Dallinger, D.; Oliver Kappe, C. Chem. Rev. 2007, 107, 2563.
20. Madrigal, A.; Grande, M.; Avendaño, C. J. Org. Chem. 1998, 63, 2724.
21. Tom, N. J.; Simon, W. M.; Frost, H. N.; Ewing, M. Tetrahedron Lett. 2004, 45, 905.
22. Isidro-Llobet, A.; Alvarez, M.; Fernando Albericio, F. Chem. Rev. 2009, 109, 2455.
23. Wang, G.; Li, C.; Li, J.; Jia, X. Tetrahedron Lett. 2009, 50, 1438.
24. Carlsson, A. C.; Jam, F.; Tullberg, M.; Pilloti, A.; Ioannidis, P.; Luthman, K.; Grøtli,
M. Tetrahedron Lett. 2006, 47, 5199.
25. López-Cobeñas, A.; Cledera, P.; Sánchez, J. D.; Pérez-Contreras, R.; López-
Alvarado, P.; Ramos, M. T.; Avendaño, C.; Menéndez, J. C. Synlett 2005, 1158.
26. Representative experimental procedure for peptide coupling:
(CDCl3, 400 MHz) d 7.05 (2H, d), 6.77 (2H, d), 5.72 (1H, s), 4.21 (1H, dd), 4.08
(1H, t), 3.66–3.59 (1H, m), 3.56- 3.51 (1H, m), 3.44–3.39 (1H, m), 2.75 (1H, dd),
2.29 (1H, m), 2.02–1.96 (1H, m), 1.94–1.83 (2H, m); 13C NMR (CDCl3, 100 MHz)
d 169.8, 165.3, 155.6, 130.5 (2C), 127.4, 116.3 (2C), 59.3, 56.4, 45.6, 36.1, 28.5,
22.7; ESI-MS (m/z): calcd for C14H16N2O3 (M+H)+: 261.1161, found: 261.1226;
[a
]
D = À71.3 (c 0.5, MeOH) [lit.29
[a]D = À72 (c 0.5, MeOH)].
28. Cledera, P.; Avendaño, C.; Menéndez, J. C. Tetrahedron 1998, 54, 12349.
29. Stierle, A. C.; Cardellina, J. H., II; Strobel, G. A. Proc. Natl. Acad. Sci. U.S.A. 1988,
82, 8008–8011.
DIEA (0.78 g, 6.0 mmol), N-Boc-L-tyrosine (0.85 g, 3.0 mmol), and HBTU (1.37 g,